FLNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FLNT is not a good immediate buy for a beginner long-term investor with $50,000-$100,000 who is impatient and does not want to wait for a better entry. The stock is oversold and close to support, which makes it interesting, but the current downtrend, negative MACD, lack of recent news catalysts, neutral insider/hedge fund activity, and no strong proprietary buy signal mean the setup is not strong enough to call a clear buy right now. I would not buy aggressively at this moment.
FLNT is trading at 2.13, below the recent close of 2.17 and under the pivot level of 2.599. The MACD histogram is negative and worsening, showing bearish momentum. RSI_6 at 14.393 signals the stock is deeply oversold, which can support a bounce, but it does not confirm a durable reversal. Moving averages are converging, suggesting a possible turning point, yet current trend structure still looks weak. Key support is near 2.247 and then 2.03, while resistance sits at 2.95 and 3.167. Overall, the trend is weak and not yet a clean long-term entry.
["Lake Street initiated coverage with a Buy rating and a $5 price target.", "Analyst commentary expects consolidated revenue to return to double-digit growth by Q4'26 and net income to turn positive.", "RSI is deeply oversold, which can support a short-term rebound.", "Mildly improved technical setup from converging moving averages."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "MACD is negative and expanding, confirming bearish momentum.", "Stock is below key pivot resistance, showing weak price structure.", "No AI Stock Picker signal today.", "No SwingMax buy signal recently.", "Hedge funds and insiders are both neutral with no notable accumulation.", "No recent congress trading data available.", "Similar candlestick pattern analysis suggests weak near-term performance."]
No usable latest-quarter financial snapshot was provided due to an error, so there is not enough reliable quarter-level financial data to assess revenue, margins, or profitability trends directly. However, analyst commentary references mixed Q4 results, with revenue and adjusted EBITDA slightly below consensus, while CMS revenue doubled and growth is expected to improve in 2026. The latest quarter season mentioned is Q4.
Analyst sentiment is improving. On 2026-03-10, Canaccord raised its price target to $3.50 from $2.50 but kept a Hold rating, reflecting cautious optimism after mixed Q4 results. On 2026-04-23, Lake Street initiated coverage with a Buy rating and a $5 target, citing a hidden growth story and expecting revenue growth and positive net income later in 2026. Wall Street’s pro case is improving growth prospects and potential earnings inflection; the con case is that current fundamentals still appear uneven and the stock remains below the more bullish target levels.
